Monday, July 27, 2015

Verrucous Carcinoma Global Clinical Trials Review, H1, 2015

. Buy Doryx with free prescription DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/khqfrb/verrucous) has announced the addition of the "Verrucous Carcinoma Global Clinical Trials Review, H1, 2015" report to their offering. "Verrucous Carcinoma Global Clinical Trials Review, H1, 2015" provides data on the Verrucous Carcinoma clinical trial scenario. Buy Tadora (Tadalafil ) with no prescription Nexium (Esomeprazole) without Rx This report provides elemental information and data relating to the clinical trials on Verrucous Carcinoma. Buy Vitex online About Keflex (Cephalexin) with no Rx It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. http://webmdconsult.wordpress.com Buy Duphaston (Dydrogesterone) with no Rx The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Verrucous Carcinoma. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type Listings of discontinued trials (suspended, withdrawn and terminated) Clinical Trial Overview of Top Companies MatrixPharm National Cancer Institute Roswell Park Cancer Institute Fox Chase Cancer Center Ohio State University Comprehensive Cancer Center Radiation Therapy Oncology Group University of Chicago Wake Forest University Abramson Cancer Center AIDS Malignancy Clinical Trials Consortium For more information visit .researchandmarkets.com/research/khqfrb/verrucous

Wednesday, July 15, 2015

Global Mycoses Pipeline Insights Study 2015

. About Voveran SR (Diclofenac) with free Rx DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/3n73v6/mycosespipeline) has announced the addition of the "Mycoses-Pipeline Insights" report to their offering. Mycoses Pipeline Insights provides the in-depth analysis of the pipeline assets across the Mycoses. Buy Soy Protein online About Imitrex (Sumatriptan) with no Rx The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. http://pharmaceuticaljournal.wordpress.com Buy Norvir (Ritonavir) without Rx The Mycoses Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. Mycoses Pipeline Insights Report covers the Mycoses pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. Suhagra (Sildenafil Citrate) with no Rx The Report also provides Mycoses related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. Desogestrel with free prescription The Report also highlights the discontinued and inactive projects in pipeline for Mycoses. Scope - The report provides a Mycoses Landscape across the globe - The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information - Coverage of the Mycoses pipeline on the basis of target, MOA, route of administration, technology involved and molecule type - The report reviews key players involved in the therapeutics development for Mycoses and also provide company profiling - Pipeline products coverage based on various stages of development from NDA filings to discovery. - Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type For more information visit .researchandmarkets.com/research/3n73v6/mycosespipeline

Tuesday, July 14, 2015

Global Meningitis Pipeline Insights Report 2015

. About Allegra (Fexofenadine) with free Rx DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/v7cf87/meningitispipelin) has announced the addition of the "Meningitis-Pipeline Insights" report to their offering. Meningitis - Pipeline Insights provides the in-depth analysis of the pipeline assets across the Meningitis. Buy R-Lipoic Acid online Detrol La (Tolterodine) without Rx The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. http://webmd-consult.blogspot.com About Rhinocort (Budesonide) The Meningitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. Meningitis - Pipeline Insights Report covers the Meningitis pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. Aralen (Chloroquine) with no prescription The Report also provides Meningitis related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. Buy Daclin with free prescription The Report also highlights the discontinued and inactive projects in pipeline for Meningitis. Scope - The report provides a Meningitis Landscape across the globe - The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information - Coverage of the Meningitis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type - The report reviews key players involved in the therapeutics development for Meningitis and also provide company profiling - Pipeline products coverage based on various stages of development from NDA filings to discovery. - Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type For more information visit .researchandmarkets.com/research/v7cf87/meningitispipelin

Monday, July 13, 2015

ESMO GI provides new insights into HCC and metastatic liver cancer

Studies presented at the European Society for Medical Oncology 17th World Congress on Gastrointestinal cancer, Barcelona, Spain,1-4 July, helped define the hepatocellular carcinoma and liver metastatic colorectal cancer patient populations in which established treatments work best and provided insights into emerging therapies. Scientists believe there is an unmet medical need for both hepatocellular carcinoma and metastatic liver cancer. Patients with hepatocellular carcinoma (HCC) have a poor prognosis with median survivals of 10 to 11 months despite use of sorafenib first line. Detrol La (Tolterodine) without Rx Liver metastases develop in nearly 20% of patients with stage II and 50% of patients with stage III colorectal cancer and represent the major cause death in this disease. About Rhinocort (Budesonide) Unfortunately, radical surgical resection of liver metastases is only possible in 10 to 25% of patients with CRC confined to the liver. Aralen (Chloroquine) with no prescription In most patients the number, localization and/or size of the liver metastases or poor hepatic reserve preclude resection. Buy Daclin with free prescription All this points to the unmet medical need for both HCC and metastatic liver cancer. The latest analysis of the GIDEON study, which set out to evaluate the safety of sorafenib in a real world population of HCC patients, showed improved outcomes for patients over 70 years compared to those under 70 years. About Allegra (Fexofenadine) with free Rx The current subgroup analysis explored 278 patients from the Italian cohort of the main study, of whom 141 were older than 70 years and 133 younger. Results showed that the median overall survival was 10 months in the younger age group versus 20 months in the older age group. Buy R-Lipoic Acid online Furthermore, elderly patients had a PFS of 6 months versus 4.1 months for younger patients; and elderly patients had a time to progression of 7.6 months versus 5 months for younger patients. http://webmd-consult.blogspot.com The authors believe that younger patients have shorter overall survivals due to more advanced disease. The latest sub-analysis from the SIRFLOX study showed patients with metastatic colorectal cancer (mCRC) that has spread only to the liver at study entry do better with selective internal radiation therapy (SIRT) than those with more widespread metastases. With SIRT, a technique granted CE Mark approval in the EU in 2002 for unresectable liver tumours, yttrium-9-resin microspheres (Sirtex) are delivered to the liver via a hepatic artery injection. Key to the success of the procedure is occlusion of extra-hepatic vessels to prevent deposition of radioactive microspheres outside the liver. Since there have never been large randomized controlled trials for SIRT in combination with modern first-line standard of care chemotherapy the SIRFLOX study was initiated. Data presented at ASCO 2015 failed to show overall progression free survival advantages for patients treated with mFOLFOX6 + SIRT compared to those treated with chemotherapy alone. The findings were attributed to the inclusion of 40% of patients with extra-hepatic metastatic disease in the analysis. In the current sub-group analysis the investigators explored the 318 patients with metastases limited to the liver at the time they entered the study separately from the 212 patients with both liver and extra hepatic metastases at study entry. Results showed that for those treated with metastases limited to the liver median PFS in the liver was 21.1 months for those treated with chemotherapy + SIRT compared to 12.4 months for those treated with chemotherapy alone (p=0.003, HR 0.64). "These new pre-planned sub-group findings for PFS in the liver should lead oncologists to consider adding SIR-Spheres Y-90 resin microspheres to first-line chemotherapy," said Guy van Hazel, the co-principal investigator of the SIRFLOX study, from the University of Western Australia, Perth. Rose bengal solution as hepatocellular carcinoma treatment According to one intriguing abstract study, a single injection with PV-10 led to the complete disappearance of HCC in one patient, and colorectal liver metastases in another. PV-10, a 10% solution of rose bengal used originally to stain necrotic tissue in the cornea, has been showing promise in melanoma. A phase 2 study, presented at ESMO last year, demonstrated that 50% of patients with stage III melanoma patients who had all their cutaneous lesions injected with PV-10 achieved a complete response. For the current study two cohorts of patients, one with non-resectable HCC (n=6) and a second with other forms of cancer metastatic to the liver (n=7, three originally colorectal tumors, two nonsmall cell lung, two melanoma and one ovarian) underwent a single percutaneous injection of PV-10 guided by CT to one target lesion in the liver at least 1 cm in diameter. From the analysis of the first five patients (who had six tumours injected) the investigators found that two patients showed no evidence of disease at more than 40 months follow-up according to RECIST and EASL criteria. The first patient was a 68 year old male with HCC (hepatitis B and cirrhosis) alive at 54 months follow-up with no evidence of disease; while the second patient was a 61-year-old male with metastatic CRC alive at 42 months follow-up with no evidence of disease. "Having liver cancer patients alive at up to 54 months follow-up with no evidence of disease is remarkable. This is even more extraordinary when you consider these patients received just one or two intralesional injections," says Eric Wachter, the author of the abstract who co-developed PV-10. As with melanoma, the mechanism of PV-10 in liver cancers is believed to be due to local chemoablative effects where the agents enters lysosomes causing tumor necrosis that can stimulate immunological effects. Furthermore, melanoma patients injected with PV-10 have been shown to have increased T cells in peripheral blood, including CD8+, CD4+, CD3+ and NKT. Written by Janet Fricker

Sunday, July 12, 2015

People with schizophrenia have more rare genetic mutations

. Buy Pregnenalone online chizophrenia is a common, complex disorder that appears to arise from a number of factors, some of which are genetic. http://medicalquestionanswers.wordpress.com About Coumadin (Warfarin) Now, a new study of the genetic mutations associated with schizophrenia has deepened our understanding of its genetic structure. The DNA screening study found that patients with schizophrenia had more rare variants of genes that code for proteins than people not affected by the condition. The international study, led by the University of California Los Angeles (UCLA), is published in the journal Nature Communications. There, the researchers describe how after screening for hundreds of thousands of genetic variants in people with and without schizophrenia, they found certain types - rare mutations that code for proteins - occur more frequently in people with the condition. First author Dr. Buy Singulair (Montelukast) Loes Olde Loohuis, of UCLA s Center for Neurobehavioral Genetics, says: "While we cannot point to specific mutations that play a causal role in schizophrenia, we show that schizophrenia patients collectively have more of these mutations than unaffected individuals." Mutations in genes that code for proteins play a key role in the development of the brain before birth, notes senior author Roel Ophoff, a professor in psychiatry and human genetics at UCLA, who adds: "Our finding further supports the hypothesis that schizophrenia is a disorder that may originate during the early stages of brain development." Schizophrenia is a common disorder characterized by hallucinations, delusions and disorganization, that can significantly impair quality of life for patients and their families. Buy Herbolax () In the US, around 2-3 million people have the condition. Rare coding variants contribute to complex genetic architecture of schizophrenia Fast facts about schizophrenia Schizophrenia is a condition that affects thinking, feeling and behavior and causes people to have abnormal experiences The condition will affect around 1 in every 100 people in their lifetime Contrary to what many believe, people with schizophrenia are rarely violent - they are more likely to be victims of violence by others. Find out more about schizophrenia For the study, the team used a commercially available DNA screening tool to search for 250,000 coding variants in 1,042 schizophrenia patients from the Netherlands and 961 unaffected individuals. A coding variant is where a gene or sequence of DNA that contains instructions for making a protein is slightly altered, thus raising the chance that the associated protein may cause malfunction in the cell in which it is made. The results of the DNA screening showed that the patients with schizophrenia had more of the variants than patients without schizophrenia. The researchers confirmed these findings in another study group of more than 13,000 people with and without schizophrenia. Prof. About Cyclospasmol without prescription Ophoff says even though we know there is a large genetic component in schizophrenia, we do not know enough about the underlying biology, and concludes: "Our research shows that rare coding variants throughout the human genome also contribute to this complex genetic architecture." In discussing their results, the authors also note that the genes containing rare coding variants "significantly overlap with genes expressed in fetal brain highlighting the potential involvement of neurodevelopment" in the causes of schizophrenia. The National Institute of Mental Health funded the research. This work follows news of another piece of research that Medical News Today reported recently that offers strong evidence of a neurological cause of schizophrenia. Arimidex (Anastrozole) with free Rx Writing in the journal Neuron, a team from the University of Cardiff in the UK describes how they found schizophrenia mutations interfere with chemical signaling in the brain. Written by Catharine Paddock PhD

Saturday, July 11, 2015

Food container plastics linked to hypertension

Chemicals supposed to be safe replacements for harmful chemicals in plastics are linked to hypertension and insulin resistance, a precursor to diabetes, find scientists from NYU Langone Medical Center in New York City. Small rises in blood pressure were linked to the chemicals supposed to replace those previously found to be unsafe. The phthalate compounds in question - di-isononyl phthalate (DINP) and di-isodecyl phthalate (DIDP) - are replacements for another chemical, di-2-ethylhexylphlatate (DEHP), which the same researchers proved in previous research to have similar adverse effects. The phthalates are meant to strengthen plastic wraps and processed food containers, among other household items. The two new pieces of research are published in the journals Hypertension and The Journal of Clinical Endocrinology and Metabolism. In the Hypertension study, for every 10-fold increase in the amount of phthalates consumed, there was a 1.1 millimeters of mercury (mmHg) increase in blood pressure. In the other study, one in three adolescents with the highest DINP levels had the highest insulin resistance, while for those with the lowest concentrations of the chemicals, only 1 in 4 had insulin resistance. Growing concerns over environmental chemicals and insulin resistance Study leader Dr. About Avodart (Dutasteride) with free prescription Leonardo Trasande, a professor at NYU Langone, says: "Our research adds to growing concerns that environmental chemicals might be independent contributors to insulin resistance, elevated blood pressure and other metabolic disorders." Prof. Buy Viagra Gold (Sildenafil Citrate + L-Arginine + Giseng + Vitamin B6 + Folic Acid) with no Rx Trasande would like the 1976 Toxic Substances Control Act updated: "Our study adds further concern for the need to test chemicals for toxicity prior to their broad and widespread use, which is not required under current federal law." Other research from Prof. Buy Theo-24 Sr (Theophylline ) with no Rx Trasande in 2013 confirmed a link between DEHP exposure and hypertension in Americans. Buy Combantrin with free Rx DEHP was used as a plasticizer but banned in Europe in 2004 - DINP and DIDP are designed to replace it. Ceclor (Cefaclor) with free Rx Perhaps the safer alternatives lie in not using plastics at all. "Alternatives to DIDP and DINP include wax paper and aluminum wrap; indeed, a dietary intervention that introduced fresh foods that were not canned or packaged in plastic reduced phthalate metabolites substantially." Prof. Buy Neem online Trasande adds that there are "safe and simple" steps that can limit exposure to phthalates, including: Do not microwave food in plastic containers or covered by plastic wrap Do not wash plastic food containers in the dishwasher, where plasticizers can leak out Avoid phthalates by avoiding plastic containers labeled with the numbers 3, 6 or 7 inside the recycle symbol. The results of the research come from blood and urine sample analysis of participants in the National Health and Nutrition Examination Survey (NHANES). Since 1999, NHANES has surveyed 5,000 volunteers annually about risk factors and diseases. http://web-md.blogspot.com As part of the NYU Langone investigation, blood and urine samples were analyzed from a diverse group of children and adolescents aged between 6 and 19 years. Blood and urine samples were collected once between 2008 and 2012, and the study volunteers blood pressure was similarly measured. Diet, physical activity, gender, race/ethnicity, income, and other factors independently associated with insulin resistance and hypertension were also factored into the researchers analysis. Written by Markus MacGill

Tuesday, July 7, 2015

Weight-loss surgery 'highly effective' for type 2 diabetes remission

A new study suggests weight-loss surgery combined with low-level lifestyle interventions may be a more effective treatment strategy for obese patients with type 2 diabetes than lifestyle interventions alone. While lifestyle interventions alone appear to have no effect on type 2 diabetes remission, researchers found these combined with weight-loss surgery led to remission for many obese patients with the condition. Dr. About Apcalis Oral Jelly (Tadalafil) with no prescription Anita P. Vpxl (Vpxl) with no prescription Courcoulas, of the University of Pittsburgh Medical Center, PA, and colleagues publish their findings in JAMA Surgery. Excess weight is a major risk factor for type 2 diabetes; more than 90% of people who have type 2 diabetes are overweight or obese. It is recommended that obese patients with type 2 diabetes adopt lifestyle changes, such as a healthy diet and regular exercise, to help manage or treat their condition. Prandin (Repaglinide) without prescription But recently, studies have suggested weight-loss surgery, or bariatric surgery, may be just as effective as lifestyle interventions and medical therapy for obese patients with type 2 diabetes In April 2014, for example, Medical News Today reported on a study published in the New England Journal of Medicine that found obese patients who underwent bariatric surgery were able to control their type 2 diabetes without the use of medical therapy in the 3 years following the procedure. But Dr. Clopress without prescription Courcoulas and colleagues say "questions remain" about the efficacy of such treatment. About Cialis Pack-30 () without Rx "More information is needed about the longer-term effectiveness and risks of all types of bariatric surgical procedures compared with lifestyle and medical management for those with T2DM [type 2 diabetes mellitus] and obesity," they note. As such, the team assessed the outcomes of 61 obese patients aged 25-55 with type 2 diabetes who were randomly assigned to receive either weight-loss surgery in the first year followed by a low-level lifestyle intervention for 2 years, or an intense lifestyle intervention for 1 year followed by a low-level lifestyle intervention for 2 years. Subjects who underwent weight-loss surgery received one of two procedures: roux-en-Y gastric bypass (RYGB) or laparoscopic adjustable gastric banding (LAGB). Buy Mullein online RYGB involves the creation of a small stomach pouch from a portion of the stomach, which is then connected to the small intestine, bypassing the rest of the stomach and the duodenum. http://cholesterolreviews.wordpress.com LAGB involves the placement of a band around the upper part of the stomach to create a smaller stomach pouch. The band can be adjusted after the procedure to make food pass more slowly or quickly through the stomach. Both of these procedures limit the amount of food a person can eat, making them feel full faster. Dr. Courcoulas and colleagues assessed the incidence of partial or complete type 2 diabetes remission among all subjects after 3 years. Weight-loss surgery led to complete type 2 diabetes remission for some obese patients Bariatric surgery was found to be most effective for weight loss among study participants. Those who underwent RYGB lost around 25% of their body weight during follow-up, LAGB subjects lost around 15% of their body weight, while lifestyle intervention-only participants lost around 5.7%. The team found that many participants who underwent weight-loss surgery followed by lifestyle interventions experienced partial or complete type 2 diabetes remission, while those who engaged in lifestyle interventions alone experienced no remission at all. Of the subjects who underwent RYGB, 40% experienced partial or complete type 2 diabetes remission, while this was the case for 29% of subjects who underwent LAGB. Three subjects treated with RYGB and one treated with LAGB had complete remission. In addition, the team found that patients who underwent weight-loss surgery were more likely to have better blood glucose control and less likely to need medication for their type 2 diabetes, compared with those who engaged in lifestyle interventions alone. "More than two thirds of those in the RYGB group and nearly half of the LAGB group did not require any medications for T2DM treatment at 3 years," say the researchers. One strength of this study, according to the team, is that around 40% of participants fell into the category of class 1 obesity - defined as having a body mass index (BMI) of between 30 and 35. The researchers note that weight-loss surgery is normally carried out on patients with a BMI of 40 or more, so data is lacking on the effects of weight-loss surgery for obese patients with a lower BMI. Commenting on their findings, the team says: "This study provides further important evidence that at longer-term follow-up of 3 years, surgical treatments, including RYGB and LAGB, are superior to lifestyle intervention alone for the remission of T2DM in obese individuals including those with a BMI between 30 and 35. While this trial provides valuable insights, unanswered questions remain such as the impact of these treatments on long-term microvascular and macrovascular complications and the precise mechanisms by which bariatric surgical procedures induce their effects." In an editorial linked to the study, Dr. Michel Gagner, of Florida International University in Miami, says the findings indicate the use of weight-loss surgery should be increased for obese individuals with type 2 diabetes. "We should consider the use of bariatric (metabolic) surgery in all severely obese patients with T2DM and start a mass treatment, similar to what was done with coronary artery bypass graft more than 50 years ago," he says. In November 2014, MNT reported on a study suggesting that weight-loss surgery may also be effective for prevention of type 2 diabetes among obese patients. Published in The Lancet Diabetes & Endocrinology, the study found that obese patients who underwent bariatric surgery were 80% less likely to develop type 2 diabetes than those who received no obesity-related treatment. Written by Honor Whiteman

Traders' testosterone 'makes them take financial risks'

Researchers simulating the financial trading floor in the lab have found that traders hormone levels in the stressful, competitive environment are raised, making them invest in more risky assets. Cortisol is involved in the fight or flight response. The study, published in Scientific Reports, found that when given doses of either cortisol or testosterone, the participants buying and selling assets among themselves invested more in risky assets. They measured the volunteers natural hormone levels in one experiment and artificially raised them in another. About Champix (Varenicline) without Rx "Our view is that hormonal changes can help us understand traders behavior, particularly during periods of financial instability," said Dr. Buy Amoxil (Amoxicillin) without Rx Carlos Cueva, PhD, one of the lead authors of the study, from the department of economics at the University of Alicante, Spain. Cortisol is elevated in response to physical or psychological stress, increasing blood sugar and preparing the body for a fight-or-flight response. The authors suggest their findings could help with the development of more stable financial institutions. The paper s conclusion is: "Our results suggest that changes in both cortisol and testosterone could play a destabilizing role in financial markets through increased risk taking behavior, acting via different behavioral pathways." Dr. Allegra (Fexofenadine) Ed Roberts, from the department of medicine at the UK s Imperial College London and one of the lead authors of the study, says: "Our aim is to understand more about what these hormones do. Cilostazol without Rx Then we can look at the environment in which traders work, and think about whether it s too stressful or too competitive. "These factors could be affecting traders hormones and having an impact on their decision-making." Saliva samples Some 142 volunteers, male and female, participated in the study, giving saliva samples for the measurement of the two hormones. They played an asset trading game in groups of around 10. Diltiazem (Diltiazem Hcl) without prescription Those who had higher levels of cortisol were more likely to take risks, and high levels in the group were associated with instability in prices. In a second experiment, 75 young men were given either cortisol or testosterone before playing the game. Buy Liver online They were tested once while on the hormone and once while on a placebo. Both hormones had an effect toward greater risk-taking in investments. http://allergy-opinion.blogspot.com Cortisol appeared to directly affect volunteers preference for riskier assets, while testosterone seemed to increase optimism about how prices would change in the future. Dr. Roberts says: "The results suggest that cortisol and testosterone promote risky investment behavior in the short run. "We only looked at the acute effects of the hormones in the lab. It would be interesting to measure traders hormone levels in the real world, and also to see what the longer term effects might be." Written by Markus MacGill

Saturday, July 4, 2015

Benefits of extracurricular sports extend into the classroom

Extracurricular sports have long been promoted as a way of keeping children healthy, but new research suggests they could also provide benefits in the classroom, helping children remain engaged and disciplined. The study suggests an association between physical activity and self-regulation from kindergarten to fourth grade. The study, published in the American Journal of Health Promotion, found that children who regularly participated in structured sports were better at following instructions and remaining focused in the classroom than their peers by the time they reached fourth grade. "There is something specific to the sporting environment - perhaps the unique sense of belonging to a team, a special group with a common goal - that appears to help kids understand the importance of respecting the rules and honoring responsibilities," explains study author Linda Pagani of the University of Montreal, Canada. For the study, Pagani and colleagues analyzed data obtained from the Quebec Longitudinal Study on Child Development on 2,694 children born between 1997 and 1998. About Hard On (Sildenafil Citrate) with free prescription She explains the aims of the study: "Our goal was to answer two questions: firstly, does participation in extracurricular activities in kindergarten predict fourth-grade self-discipline, and secondly, do kindergarten self-discipline characteristics predict fourth-grade participation in sports?" Information was provided by both the teachers and parents of children in kindergarten, detailing the behavior of the children while in school and at home. About Atrovent (Ipratropium Bromide) with free prescription Four years later, when the children had reached fourth grade, the information-gathering exercise was repeated. Once they had obtained the data, the researchers took into account other factors that could have influenced their findings such as the children s physical fitness, parental education levels and how well the family unit functioned. The researchers found that children who participated in structured activities such as sports while at kindergarten were more likely to be involved in sports by the time they reached fourth grade. Buy Actigall (Ursodeoxycholic acid) with no prescription In contrast, participating in unstructured activities had no impact on the child s future. Extracurricular sports could prevent kids from being left behind "Across the board, we found that children who had better behavior in the kindergarten class were more likely to be involved in sport by age 10," reports Pagani. Buy Cevibid "Nonetheless, we found that those children who were specifically involved in team sports at kindergarten scored higher in self-regulation by the time they reached fourth grade." According to the researchers, sporting activities and attention skills are intrinsically linked, and school planning can use this association to the benefit of pupils. Elavil (Amitriptyline) without prescription Additionally, pupils deemed to be at risk of not getting enough exercise could be targeted to improve both obesity and school drop-out rates. "Programs to help parents develop their child s self-regulation skills and the availability of extracurricular sports programs as early as kindergarten could help decrease the risk of kids being left behind," Pagani suggests. The researchers hope that their findings can be of use to policymakers outside of schools as well, leading to improved access to parks and playgrounds for children and their families and to promoting active schools and communities as a whole. According to a report released this past December by the US Census Bureau, there are a large number of children that do not currently participate in extracurricular activities. Buy L-Proline online Although children were found to be more likely to participate in sports than other activities, only 57% of children aged 6-17 participate in at least one after-school extracurricular activity. The report identified household structure as a factor that influenced how likely a child was to be involved in extracurricular activities. http://asthmareview.wordpress.com Children whose parents were married and lived together were more likely to participate than children living with cohabiting parents or a single parent. Recently, Medical News Today reported on a study finding that when teenagers exercise like young children - in short bursts of intense activity - their health outcomes are improved. Written by James McIntosh

Friday, July 3, 2015

Placebos 'relieve symptoms, improve treatments'

Scientists suggest that the placebo effect should be considered as an important tool in relieving the symptoms of patients and improving other therapeutics, writing in an article that these "dummy" treatments are underappreciated by the medical community. Placebos have been used for centuries to relieve pain and other symptoms as well as in clinical trials to test new drugs. The paper, published in The New England Journal of Medicine, states that recent research indicates placebo effects are rooted in neurobiology and can be valuable in and of themselves. "Placebos don t necessarily provide cures, but they provide relief," explains coauthor Prof. Buy Vantin (Cefpodoxime) with no prescription Ted Kaptchuk, of Beth Israel Deaconess Medical Center (BIDMC). Ciloxan (Ciprofloxacin) with no prescription "In medical situations in which no cure is available, supportive and attentive health care can help patients to feel better, and when effective drugs do exist, placebo effects can enhance their impact." Dummy pills are often used in clinical trials as a means to test whether new drug therapies work or not, although they have also been used as a way of treating pain and other symptoms for centuries. According to the authors, improvements in patients symptoms are due to participation in a therapeutic encounter and precipitated by contextual cues such as identifiable health care objects and the interaction between patient and physician. "A significant body of research has resulted in a shift from thinking of placebos as just dummy treatments to recognizing that placebo effects encompass numerous aspects of the health care experience and are central to medicine and patient care," explains Prof. About Acticin (Permethrin) without Rx Kaptchuk, also Professor of Medicine at Harvard Medical School. He demonstrates how opinions of placebos have changed by referring to a meta-analysis published in 2001 - also in The New England Journal of Medicine - which concluded that placebo effects are insignificant. About Cardinol with free prescription Since that study, placebos have gone on to become more prominent in medical practice. "Recent scientific advances have enabled us to identify a trove of neurotransmitters and detect relevant neural brain pathways as well as genetic markers that help explain the biology of the placebo effect," says Prof. About Grifulvin (Griseofulvin) Kaptchuk. Buy Hawthorn online These pathways are also used by many common medications, enhancing the credibility of the placebo effect. At the core of what makes medicine a healing profession Clinical studies have also demonstrated that placebos can significantly improve the effectiveness of pharmaceutical therapies. http://medicalhelper.wordpress.com Research into the treatment of migraine headache and irritable bowel syndrome in particular has shown how important the placebo effect can be in the relief of certain specific symptoms: "For example, a recent study of episodic migraine demonstrated that when patients took rizatriptan (10 mg) that was labeled placebo (a treatment that theoretically had pure pharmacologic effects ), the outcomes did not differ from those in patients given placebos deceptively labeled rizatriptan (pure expectation effect). However, when rizatriptan was correctly labeled rizatriptan, its analgesic effect increased by 50%." Alongside these benefits, however, researchers have identified that the psychosocial factors behind the placebo effect can also lead to adverse consequences due to the anticipation of negative effects. These changes are known as nocebo effects. The nocebo effect is one problem with placebos that researchers need to address, the authors write. The other is the fact that most of the discoveries around the placebo effect have come from experiments involving "healthy volunteers, employing deceptive techniques that are not directly pertinent to clinical practice." Prof. Kaptchuk and coauthor Franklin Miller, PhD, call for more creative thinking and experimental research specifically focusing on placebo and nocebo effects, in order to improve the way that this form of medication is administered. "Of course, placebo effects are modest as compared with the impressive results achieved by lifesaving surgery and powerful, well-targeted medications," the authors conclude. "Yet we believe such effects are at the core of what makes medicine a healing profession." Earlier this year, Medical News Today reported on a study finding that the more expensive Parkinson s drugs are, the more powerful the placebo effect is. Written by James McIntosh

Placebos 'relieve symptoms, improve treatments'

Scientists suggest that the placebo effect should be considered as an important tool in relieving the symptoms of patients and improving other therapeutics, writing in an article that these "dummy" treatments are underappreciated by the medical community. Placebos have been used for centuries to relieve pain and other symptoms as well as in clinical trials to test new drugs. The paper, published in The New England Journal of Medicine, states that recent research indicates placebo effects are rooted in neurobiology and can be valuable in and of themselves. "Placebos don t necessarily provide cures, but they provide relief," explains coauthor Prof. Buy Vantin (Cefpodoxime) with no prescription Ted Kaptchuk, of Beth Israel Deaconess Medical Center (BIDMC). Ciloxan (Ciprofloxacin) with no prescription "In medical situations in which no cure is available, supportive and attentive health care can help patients to feel better, and when effective drugs do exist, placebo effects can enhance their impact." Dummy pills are often used in clinical trials as a means to test whether new drug therapies work or not, although they have also been used as a way of treating pain and other symptoms for centuries. According to the authors, improvements in patients symptoms are due to participation in a therapeutic encounter and precipitated by contextual cues such as identifiable health care objects and the interaction between patient and physician. "A significant body of research has resulted in a shift from thinking of placebos as just dummy treatments to recognizing that placebo effects encompass numerous aspects of the health care experience and are central to medicine and patient care," explains Prof. About Acticin (Permethrin) without Rx Kaptchuk, also Professor of Medicine at Harvard Medical School. He demonstrates how opinions of placebos have changed by referring to a meta-analysis published in 2001 - also in The New England Journal of Medicine - which concluded that placebo effects are insignificant. About Cardinol with free prescription Since that study, placebos have gone on to become more prominent in medical practice. "Recent scientific advances have enabled us to identify a trove of neurotransmitters and detect relevant neural brain pathways as well as genetic markers that help explain the biology of the placebo effect," says Prof. About Grifulvin (Griseofulvin) Kaptchuk. Buy Hawthorn online These pathways are also used by many common medications, enhancing the credibility of the placebo effect. At the core of what makes medicine a healing profession Clinical studies have also demonstrated that placebos can significantly improve the effectiveness of pharmaceutical therapies. http://medicalhelper.wordpress.com Research into the treatment of migraine headache and irritable bowel syndrome in particular has shown how important the placebo effect can be in the relief of certain specific symptoms: "For example, a recent study of episodic migraine demonstrated that when patients took rizatriptan (10 mg) that was labeled placebo (a treatment that theoretically had pure pharmacologic effects ), the outcomes did not differ from those in patients given placebos deceptively labeled rizatriptan (pure expectation effect). However, when rizatriptan was correctly labeled rizatriptan, its analgesic effect increased by 50%." Alongside these benefits, however, researchers have identified that the psychosocial factors behind the placebo effect can also lead to adverse consequences due to the anticipation of negative effects. These changes are known as nocebo effects. The nocebo effect is one problem with placebos that researchers need to address, the authors write. The other is the fact that most of the discoveries around the placebo effect have come from experiments involving "healthy volunteers, employing deceptive techniques that are not directly pertinent to clinical practice." Prof. Kaptchuk and coauthor Franklin Miller, PhD, call for more creative thinking and experimental research specifically focusing on placebo and nocebo effects, in order to improve the way that this form of medication is administered. "Of course, placebo effects are modest as compared with the impressive results achieved by lifesaving surgery and powerful, well-targeted medications," the authors conclude. "Yet we believe such effects are at the core of what makes medicine a healing profession." Earlier this year, Medical News Today reported on a study finding that the more expensive Parkinson s drugs are, the more powerful the placebo effect is. Written by James McIntosh